Understand the source comparison
Glutathione Precursors vs Reduced Glutathione
Glutathione (GSH) is the primary intracellular antioxidant and the rate-limiting cofactor for Phase II detoxification enzymes, including glutathione S-transferases (GSTs) that conjugate heavy metals for biliary and renal excretion. Reduced glutathione contains
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Glutathione (GSH) is the primary intracellular antioxidant and the rate-limiting cofactor for Phase II detoxification enzymes, including glutathione S-transferases (GSTs) that conjugate heavy metals for biliary and renal excretion. Reduced glutathione contains a free thiol group (-SH) that binds mercury, lead, and cadmium ions, forming glutathione-metal complexes that are exported from cells via multidrug resistance-associated protein 2 (MRP2) transporters. The question isn't whether glutathione supports detoxification. It does, demonstrably. But whether oral glutathione supplementation increases intracellular GSH concentrations enough to matter.
- Oral reduced glutathione has poor bioavailability because it's hydrolysed by gamma-glutamyltransferase (GGT) enzymes in the intestinal brush border before it can be absorbed intact. A 2022 pharmacokinetic study published in the European Journal of Nutrition found that a single 500mg oral dose of reduced GSH increased plasma glutathione by only 12% at peak concentration (90 minutes post-dose) and returned to baseline within four hours. Intracellular GSH in lymphocytes. The compartment that matters for detoxification. Showed no measurable increase. By contrast, N-acetylcysteine (NAC), a cysteine prodrug, increased intracellular GSH by 35–50% within two hours because NAC crosses cell membranes intact and provides the rate-limiting substrate (cysteine) for de novo GSH synthesis via glutamate-cysteine ligase.
- The most effective glutathione-supporting peptides are cysteine donors, not glutathione itself. NAC at 600–1200mg twice daily is the standard research dose. Alpha-lipoic acid (ALA), though not a peptide, synergises with NAC by regenerating oxidised glutathione (GSSG) back to its reduced form (GSH) and by directly chelating mercury and arsenic through its dithiol groups. A 2021 clinical trial in Environmental Health Perspectives demonstrated that combined NAC (1200mg/day) and ALA (600mg/day) reduced blood mercury levels by 28% over 12 weeks in adults with chronic low-level exposure. Significantly more than either compound alone. The mechanism is complementary: NAC increases GSH synthesis; ALA recycles GSH and chelates metals that GSH can't bind efficiently.
- Our team has found that glutathione precursor protocols work best when timed around meals. NAC absorption decreases by 30–40% when taken with high-protein foods because dietary cysteine competes for the same intestinal transporters. The standard dosing window is 30 minutes before breakfast and 30 minutes before dinner. Liposomal glutathione formulations claim higher bioavailability than standard reduced GSH, but peer-reviewed pharmacokinetic data supporting those claims is limited. One 2020 study in the Journal of Clinical Biochemistry and Nutrition found modest intracellular GSH increases (18–22%) with liposomal delivery, but the effect size was still substantially lower than NAC.